A Group of 11 Hospitals Prepare for COVID-19 with Bioquell Technology

22 pieces of Bioquell equipment are destined for Eastern Europe, where the technology will be deployed across 11 hospitals. The systems will be used to decontaminate hospital rooms following confirmed cases of the novel coronavirus (COVID-19), as well as many other challenging pathogens that continue to persist alongside the current global outbreak.

Bioquell’s hydrogen peroxide vapour technology has been chosen due to its proven ability to reliably and homogeneously decontaminate a patient room, backed by extensive independently published data that supports the use of the technology against a wide range of challenging organisms.